The consortium led by The University of Oxford is fast-tracking clinical trials beginning in April 2020 PORT WASHINGTON, N.Y. — Pall Corporation, a global leader in filtration, separation and purification, today announced its participation in a consortium led by the Jenner Institute, University of Oxford (Oxford, England), to rapidly develop, scale-up and produce a […]
Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis […]
panCELLa and CCRM collaborate to benefit academia and industry Toronto, ON — Toronto-based panCELLa and CCRM have executed a collaboration agreement using novel technology to generate commercial-use and clinical-grade iPSC lines which will be made available to academia and industry to enable the development of new therapies. “panCELLa is an innovative company and a key […]
London, UK / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell […]
Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. — Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day review […]
Humanized IN MATRICO(TM) Lung Fibrosis Assay provides insight into efficacy of drug candidates consistent with clinical results, increasing predictiveness and accelerating decision making in development of drugs for lung fibrosis NEW YORK — Xylyx Bio, a pioneer in advanced biological systems for drug development, today announced availability of products that recreate the lung environment in vitro to provide a […]
Turin-Italy and Utrecht-the Netherlands — The ultra-modern Department of Molecular Biotechnology and Health Sciences of the University of Turin has acquired MILabs cutting edge multi-modality VECTor6CT molecular imaging system. The high-resolution and ultra-sensitive PET, SPECT and CT modalities will be used by UNITO to optimize the targeting vectors of novel probes for disease diagnostics and […]
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion SAN ANTONIO, TX – Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes from StemBioSys. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or […]
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes Supports global efforts to develop therapeutics, diagnostic assay components and vaccines to combat the COVID-19 Coronavirus pandemic Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene […]
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its COVID-19 vaccine candidate, ChAdOx1 nCoV-19. DARMSTADT, GERMANY Recently developed manufacturing platform allows large-scale manufacturing Joint team reduced process development time to two months from a year – a critical step to manufacturing COVID-19 vaccine at […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
